Your browser doesn't support javascript.
loading
Distinct effects of rosuvastatin and rosuvastatin/ezetimibe on senescence markers of CD8+ T cells in patients with type 2 diabetes mellitus: a randomized controlled trial.
Ju, Sang-Hyeon; Lim, Joung Youl; Song, Minchul; Kim, Ji Min; Kang, Yea Eun; Yi, Hyon-Seung; Joung, Kyong Hye; Lee, Ju Hee; Kim, Hyun Jin; Ku, Bon Jeong.
Affiliation
  • Ju SH; Division of Endocrinology and Metabolism, Department of Internal Medicine, Chungnam National University Hospital, Daejeon, Republic of Korea.
  • Lim JY; Division of Endocrinology and Metabolism, Department of Internal Medicine, Chungnam National University Hospital, Daejeon, Republic of Korea.
  • Song M; Division of Endocrinology and Metabolism, Department of Internal Medicine, Chungnam National University Hospital, Daejeon, Republic of Korea.
  • Kim JM; Division of Endocrinology and Metabolism, Department of Internal Medicine, Chungnam National University Sejong Hospital, Sejong, Republic of Korea.
  • Kang YE; Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon, Republic of Korea.
  • Yi HS; Division of Endocrinology and Metabolism, Department of Internal Medicine, Chungnam National University Hospital, Daejeon, Republic of Korea.
  • Joung KH; Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon, Republic of Korea.
  • Lee JH; Division of Endocrinology and Metabolism, Department of Internal Medicine, Chungnam National University Hospital, Daejeon, Republic of Korea.
  • Kim HJ; Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon, Republic of Korea.
  • Ku BJ; Department of Medical Science, Chungnam National University School of Medicine, Daejeon, Republic of Korea.
Front Endocrinol (Lausanne) ; 15: 1336357, 2024.
Article de En | MEDLINE | ID: mdl-38586464
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Azétidines / Inhibiteurs de l'hydroxyméthylglutaryl-CoA réductase / Diabète de type 2 / Hypercholestérolémie / Anticholestérolémiants Limites: Humans Langue: En Journal: Front Endocrinol (Lausanne) Année: 2024 Type de document: Article Pays de publication: Suisse
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Azétidines / Inhibiteurs de l'hydroxyméthylglutaryl-CoA réductase / Diabète de type 2 / Hypercholestérolémie / Anticholestérolémiants Limites: Humans Langue: En Journal: Front Endocrinol (Lausanne) Année: 2024 Type de document: Article Pays de publication: Suisse